CN102784313B - 一种治疗脑血栓藏药的制备方法 - Google Patents
一种治疗脑血栓藏药的制备方法 Download PDFInfo
- Publication number
- CN102784313B CN102784313B CN201210329234.1A CN201210329234A CN102784313B CN 102784313 B CN102784313 B CN 102784313B CN 201210329234 A CN201210329234 A CN 201210329234A CN 102784313 B CN102784313 B CN 102784313B
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- cerebral thrombosis
- treatment
- active component
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 201000001429 Intracranial Thrombosis Diseases 0.000 title claims abstract description 68
- 206010008132 Cerebral thrombosis Diseases 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 23
- 244000293323 Cosmos caudatus Species 0.000 claims description 13
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 13
- 239000009609 fructus phyllanthi Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000007560 sedimentation technique Methods 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000004087 circulation Effects 0.000 abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 235000015489 Emblica officinalis Nutrition 0.000 abstract description 2
- 241000305491 Gastrodia elata Species 0.000 abstract description 2
- 206010043540 Thromboangiitis obliterans Diseases 0.000 abstract description 2
- 210000000941 bile Anatomy 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 208000010125 myocardial infarction Diseases 0.000 abstract description 2
- 201000005060 thrombophlebitis Diseases 0.000 abstract description 2
- 241000218176 Corydalis Species 0.000 abstract 1
- 241001495448 Impatiens <genus> Species 0.000 abstract 1
- 240000009120 Phyllanthus emblica Species 0.000 abstract 1
- 241000282458 Ursus sp. Species 0.000 abstract 1
- 229930190166 impatien Natural products 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- 239000013641 positive control Substances 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 239000008727 tongluo Substances 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010053567 Coagulopathies Diseases 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000035602 clotting Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 206010002660 Anoxia Diseases 0.000 description 3
- 241000976983 Anoxia Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000007953 anoxia Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 241000879903 Pteria Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001533085 Aquilaria sinensis Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000382825 Cristaria plicata Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000023661 Haematological disease Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000382840 Hyriopsis cumingii Species 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 241001464055 Pteriidae Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 241000217379 Unionidae Species 0.000 description 1
- 241000282443 Ursidae Species 0.000 description 1
- 241000282453 Ursus americanus Species 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001792 thromboblast Anatomy 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210329234.1A CN102784313B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗脑血栓藏药的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210329234.1A CN102784313B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗脑血栓藏药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102784313A CN102784313A (zh) | 2012-11-21 |
CN102784313B true CN102784313B (zh) | 2014-06-11 |
Family
ID=47150030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210329234.1A Active CN102784313B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗脑血栓藏药的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102784313B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757569A (zh) * | 2010-01-19 | 2010-06-30 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗脑血栓、脑梗塞的中药组合物及其制备方法 |
CN102441081A (zh) * | 2011-11-21 | 2012-05-09 | 宋永心 | 一种治疗痛风病的药物及其制备方法 |
-
2012
- 2012-09-07 CN CN201210329234.1A patent/CN102784313B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757569A (zh) * | 2010-01-19 | 2010-06-30 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗脑血栓、脑梗塞的中药组合物及其制备方法 |
CN102441081A (zh) * | 2011-11-21 | 2012-05-09 | 宋永心 | 一种治疗痛风病的药物及其制备方法 |
Non-Patent Citations (5)
Title |
---|
刘宪勇等.珍龙醒脑胶囊辅助治疗脑血栓50例疗效观察.《山东医药》.2010,第50卷(第9期),99-100. * |
周慎.中医药治疗脑血栓形成的临床述评.《湖南中医杂志》.1992,(第2期),44-47. * |
尚远宏等.藏药的研究现状及展望.《西南民族大学学报 自然科学版》.2006,第32卷(第1期),140-144. * |
支楠.苏心通脑灵治疗脑血栓形成120例疗效观察.《中国中西医结合杂志》.1997,第17卷(第2期),101-102. * |
高健等.夏天无总碱对大鼠实验性脑血栓形成的影响.《中国血液流变学杂志》.2003,第13卷(第4期),325-326. * |
Also Published As
Publication number | Publication date |
---|---|
CN102784313A (zh) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103638404B (zh) | 一种解毒止痒杀菌药膏及其制备方法 | |
CN103446534A (zh) | 治疗精神病的药物 | |
CN104173458B (zh) | 一种具有防治高尿酸血症作用的中药组合物及其制备方法 | |
CN105031454A (zh) | 用于治疗肺结核的药物 | |
CN102793860B (zh) | 一种治疗脑血栓的藏药 | |
CN105456818A (zh) | 一种含有艾叶的治疗失眠的中药组合物及其制备方法 | |
CN102028865A (zh) | 一种化痰止咳的药物组合物及其制备方法 | |
CN102784313B (zh) | 一种治疗脑血栓藏药的制备方法 | |
CN101912442A (zh) | 一种治疗上呼吸道感染的微型灌肠剂及其制备方法 | |
CN102949572A (zh) | 一种治疗咽喉疾病的药物组合物及其制备方法 | |
CN100394976C (zh) | 一种中药戒毒药物 | |
CN102526384B (zh) | 一种用于治疗风湿的药物及其制备方法 | |
CN101524447A (zh) | 一种治疗便秘的药物组合及其制备工艺 | |
CN101244181B (zh) | 具有祛风胜湿、活血化瘀、通络止痛的骨痹膏药及其制备方法 | |
CN109999098A (zh) | 一种用于治疗肿瘤相关性睡眠障碍的中药外用制剂 | |
CN103933277A (zh) | 一种治疗痛风病的藏药 | |
CN103330858B (zh) | 一种治疗脑血栓的藏药及其制备方法 | |
CN102335360B (zh) | 一种治疗精神疾病的中药 | |
CN107510765A (zh) | 一种治疗痰瘀痹络型风湿痹症的中药组合物及其制备方法 | |
CN103230485B (zh) | 一种治疗帕金森综合症的药物及其制备方法 | |
CN102335304B (zh) | 一种祛风燥湿活血止痛的中药组合物及其制备方法 | |
CN102961680B (zh) | 一种治疗胆结石、胆囊炎的中药制剂及其制备方法 | |
CN103301371B (zh) | 一种治疗原发性遗尿敷脐剂的制备方法 | |
CN103948805A (zh) | 一种治疗胃痛的中药制剂 | |
CN104208427A (zh) | 用于治疗肾病综合征的药物制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160530 Address after: 810000 18, No. three, Qinghai biological science and Technology Industrial Park, Qinghai, Xining Patentee after: Qinghai Tibetan Hospital Co.,Ltd. Address before: 810003 Xining biological science and Technology Industrial Park, No. three, No. 18, Qinghai Patentee before: Jiumei Pengcuo |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240229 Address after: Room 1231, Building 11, No. 90 Wusi West Road, Chengxi District, Xining City, Qinghai Province, 810000 Patentee after: Yang Cuoji Country or region after: China Address before: 810000, No.18 Jingsan Road, Qinghai Biotechnology Industrial Park, Xining City, Qinghai Province Patentee before: Qinghai Tibetan Hospital Co.,Ltd. Country or region before: China |